RUNX1 and myelodysplastic syndrome: We tested this hypothesis through investigation of two preleukemia mouse models Idh1R132H and RUNX1-RUNX1T1[RT1(9a)] (17), which together represent up to 25% of human AML disease (7, 16, 18).